Lee Ainslie Maverick Capital
Lee Ainslie is the founder of Maverick Capital, a long/short equity firm that emerged from the Tiger Management network of investors. Maverick is known for fundamental research, sector specialization among teams, and a classic hedge fund long/short structure. Ainslie’s firm remains a reference name among so-called Tiger Cub managers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Seer Inc
SEER
|
+$345M |
| 2 |
Applied Materials
AMAT
|
+$164M |
| 3 |
MGM Resorts International
MGM
|
+$129M |
| 4 |
Corpay
CPAY
|
+$110M |
| 5 |
Adobe
ADBE
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$158M |
| 2 |
Corning
GLW
|
+$146M |
| 3 |
Dollar Tree
DLTR
|
+$137M |
| 4 |
KKR & Co
KKR
|
+$77.9M |
| 5 |
DuPont de Nemours
DD
|
+$75.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.08% |
| 2 | Healthcare | 21.96% |
| 3 | Consumer Discretionary | 18.94% |
| 4 | Communication Services | 13.8% |
| 5 | Materials | 6.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MIME
376
DELISTED
Mimecast Limited
MIME
| $459K | 0.01% |
8,067
-15,683
| -66% | -$725K |
|
377
Oneok
OKE
$58.8B
| $456K | 0.01% |
+11,888
| New | +$400K |
|
|
CMLFU
378
DELISTED
CM Life Sciences, Inc. Unit
CMLFU
| $456K | 0.01% |
39,302
-487,668
| -93% | -$5.25M |
|
379
Asbury Automotive
ABG
$3.86B
| $451K | 0.01% |
3,096
-6,953
| -69% | -$862K |
|
380
Diamondback Energy
FANG
$59B
| $451K | 0.01% |
+9,323
| New | +$345K |
|
|
CXO
381
DELISTED
CONCHO RESOURCES INC.
CXO
| $450K | 0.01% |
7,714
-11,223
| -59% | -$591K |
|
|
MNTV
382
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $445K | 0.01% |
+17,409
| New | +$392K |
|
383
Melco Resorts & Entertainment
MLCO
$2.09B
| $444K | 0.01% |
23,925
-15,717
| -40% | -$273K |
|
|
WGSWW
384
DELISTED
GeneDx Holdings Warrant
WGSWW
| $444K | 0.01% |
+162,796
| New | +$409K |
|
|
P
385
Everpure Inc
P
$36.1B
| $438K | 0.01% |
19,385
+13,019
| +205% | +$250K |
|
386
Teva Pharmaceuticals
TEVA
$43.5B
| $431K | 0.01% |
44,674
-80,503
| -64% | -$771K |
|
387
STAAR Surgical
STAA
$1.16B
| $430K | 0.01% |
5,432
+471
| +9% | +$34.5K |
|
388
Pegasystems
PEGA
$5.52B
| $427K | 0.01% |
6,408
+2,720
| +74% | +$174K |
|
|
VSTO
389
DELISTED
Vista Outdoor Inc.
VSTO
| $425K | 0.01% |
17,874
-16,071
| -47% | -$343K |
|
390
ICU Medical
ICUI
$4.57B
| $420K | 0.01% |
+1,957
| New | +$380K |
|
391
Affiliated Managers Group
AMG
$9.21B
| $418K | 0.01% |
4,109
-13,309
| -76% | -$1.15M |
|
|
VRNT
392
DELISTED
Verint Systems
VRNT
| $414K | 0.01% |
+12,088
| New | +$343K |
|
|
AYX
393
DELISTED
Alteryx Inc
AYX
| $413K | 0.01% |
+3,395
| New | +$428K |
|
394
Pediatrix Medical
MD
$2.16B
| $411K | 0.01% |
16,742
-100,664
| -86% | -$1.89M |
|
|
SAIL
395
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $411K | 0.01% |
7,728
-21,553
| -74% | -$1.01M |
|
|
SIX
396
DELISTED
Six Flags Entertainment Corp.
SIX
| $410K | 0.01% |
+12,014
| New | +$329K |
|
397
WEX
WEX
$6.81B
| $407K | 0.01% |
2,002
-3,294
| -62% | -$554K |
|
398
DTE Energy
DTE
$28.1B
| $404K | 0.01% |
+3,907
| New | +$412K |
|
|
TWOU
399
DELISTED
2U Inc
TWOU
| $404K | 0.01% |
+336
| New | +$360K |
|
|
ICPT
400
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $401K | 0.01% |
+16,242
| New | +$538K |
|
Similar funds
Lee Ainslie's Q4 2020 Portfolio in Review
As of Q4 2020, Lee Ainslie held 832 positions worth $6.25B, up 16% from $5.38B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Lee Ainslie's Q4 2020 filing shows 271 new, 110 increased, 277 reduced and 171 closed positions. Its largest new stake was Seer Inc: 5,425,513 shares worth $279M. The largest sale was Humana, an estimated $158M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Lee Ainslie's largest Q4 2020 buy was Seer Inc: 5,425,513 shares worth $279M.
- Lee Ainslie added most to Applied Materials in Q4 2020, an estimated $164M increase.
- Lee Ainslie's biggest Q4 2020 reduction was Humana, cutting an estimated $158M.
- Lee Ainslie fully exited Dollar Tree in Q4 2020, selling an estimated $137M.
- Lee Ainslie's ten largest holdings make up 45% of its $6.25B portfolio in Q4 2020.
- Lee Ainslie opened 271 new positions and closed 171 in Q4 2020.
- Lee Ainslie's portfolio value rose 16% quarter-over-quarter to $6.25B.
Based on Maverick Capital's 13F filing for Q4 2020, filed 16 Feb 2021.